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Background/Aims: The proper treatment of subclinical hypothyroidism and the normal range of serum thyroid stimulating 
hormone (TSH) concentration are intensely debated. However, few reports have investigated TSH concentrations in Asian 
ethnic groups. Therefore, the present study was designed to define the TSH reference range in a Korean population and 
to investigate the metabolic significance of TSH concentration.
Methods: We enrolled patients who underwent medical examination at the CHA Bundang Medical Center. Anthropomet-
ric data were evaluated, and serum TSH, free T4, and lipid profiles were assayed. 
Results: A total of 7,270 subjects were included. Mean TSH concentration of the study population was 1.82 ± 0.95 mU/L, 
and we observed a sex-related difference in TSH concentration (male, 1.67 ± 0.87 mU/L; female, 2.02 ± 1.01 mU/L; p < 0.01). 
When the 2.5 and 97.5 percentiles were calculated, 95% TSH reference limits were 0.52-4.29 mU/L. TSH concentration 
was higher in elderly subjects, during winter, in postmenopausal women, and in obese males. Moreover, TSH showed sig-
nificantly positive correlations with serum total cholesterol, triglyceride, and low density lipoprotein cholesterol regardless 
of sex, age, season, obesity, or menopausal status (all p < 0.01). Finally, TSH concentration was positively related to the 
prevalence of metabolic syndrome. 
Conclusions: We demonstrated the association between TSH concentration within the normal reference range and se-
rum lipid levels. TSH concentration varies according to sex, age, season, and body mass index (only in males). Moreover, 
high normal TSH levels were significantly associated with an increased prevalence of metabolic syndrome, which may be 
of importance when evaluating subjects with high normal TSH concentration.
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INTRODUCTION
   
Thyroid stimulating hormone (TSH) which is secreted 
by the pituitary gland, has an inverse logarithmic relation-
ship with free thyroxine (fT4) [1]. Because small changes 
in serum fT4 concentration can lead to more dramatic 
changes in serum TSH, measurement of the latter is one 
of the most sensitive methods of screening for thyroid 
dysfunction [2]. The laboratory reference range is usually 
defined by using the 95% confidence limits of a popula-
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tion of subjects without known thyroid dysfunction. Some 
reports define the lower limit of TSH as 0.2-0.4 mU/L and 
the upper limit as 2.4-4.2 mU/L [1,2]. The third National 
Health and Nutrition Examination Survey NHANES III 
(1988-1994) found that the laboratory reference range, de-
fined from values in the normal population, was 0.4-4.12 
mU/L. Results also showed ethnic difference in TSH con-
centration among White, Black, and Mexican American 
respondents. Therefore, questions are increasingly being 
raised over whether the normal range of TSH concentra-
tions in Asians is similar to that in Caucasians.
With the increasing awareness of subclinical forms of 
hyperthyroidism and hypothyroidism and increasing 
concern about thyroid disease in Korea, routine health ex-
aminations that include thyroid function are increasingly 
popular. There are few controversies regarding diagnosis 
and management of subclinical hyperthyroidism, as the 
adverse effects of subclinical hyperthyroidism such as 
osteoporosis, cardiovascular disease, and arrhythmia are 
well-known [3]. In contrast, the definition of subclinical 
hypothyroidism with reference to the normal TSH concen-
tration range remains debated [4-6]. 
Overt thyroid disease is associated with atherosclerotic 
cardiovascular disease; this is an unambiguous sign of 
overt hypothyroidism [7,8] and results from hypercholes-
terolemia and elevated blood pressure. However, whether 
subjects with subclinical hypothyroidism, defined as an 
elevated serum TSH and normal range of fT4, have such 
adverse cardiovascular disease remains uncertain and 
controversial. Several studies have reported that serum 
cholesterol level is elevated in patients with subclinical 
hypothyroidism [9,10] and is reversed by L-thyroxine 
treatment [10,11]. Another report suggested that the lipid 
profile of hypercholesterolemic patients with TSH levels 
between 2 and 4 mU/L, currently regarded as a normal 
TSH concentration, improved after low-dose L-thyroxine 
treatment [12]. Considering that metabolic syndrome rep-
resents a cluster of cardiovascular risk factors and that 
subjects who are at risk for developing cardiovascular dis-
ease are euthyroid, whether TSH contributes to metabolic 
syndrome should be investigated.
In this study we report the TSH reference range in a 
Korean population and the metabolic significance of TSH 
concentration. We aimed to investigate the factors associ-
ated with TSH concentration and the relationship between 
TSH and lipid concentration. We also evaluated the impact 
of TSH concentration on the prevalence of metabolic syn-
drome.
METHODS
Participants
From January to December, 2006, 12,143 subjects 
were recruited from the medical examination center at 
the CHA Bundang Medical Center in Korea. All subjects 
(male, 57.3%; female, 42.7%) were older than 19 years and 
in good health, and none was pregnant. All completed a 
health questionnaire that included smoking, alcohol use, 
menopausal status, past medical history, and the use of 
thyroxine or antithyroid and lipid lowering medication. 
Hospital records were also checked to identify and exclude 
patients with serious systemic diseases not reported in the 
questionnaire. Among 12,143 subjects, 4,161 lacking a fT4 
or lipid profile, 109 reported to have had thyroid disease, 
503 who showed thyroid dysfunction, and 100 who were 
taking anti-hyperlipidemic medication were excluded. Fi-
nally, 7,270 subjects were included in the analysis. 
Definitions
Euthyroidism was defined as a TSH within the refer-
ence range of 0.35-5.5 mU/L and fT4 within the reference 
range of 0.89-1.76 ng/dL (to convert to pmol/L, multiply 
by 12.871). Height and weight were measured with partici-
pants in light clothing wearing no shoes and was recorded 
to the nearest 0.1 cm and 0.1 kg. Waist circumference was 
measured at the midpoint between the lateral iliac crest 
and the lowest rib. Body mass index (BMI) was calculated 
as weight in kilograms divided by the square of height in 
meters. Obesity was defined as a BMI ≥ 25 kg/m
2, as pro-
posed by the Asia-Pacific obesity guidelines [13]. 
Smoking status at baseline was defined as never, previ-
ous, or current smoking. Blood pressure was measured 
at the right upper arm with a random-zero mercury 
sphygmomanometer in the sitting position. Seasons were 
defined as follows: spring, from March to May; summer, 
from June to August; fall, from September to November; 
and winter, from December to February. According to the 
Adult Treatment Panel (ATP) III criteria [14], metabolic 
syndrome was defined as the presence of any three of 
the following: waist circumference greater than 90 cm in 
males or 80 cm in females, triglycerides of 150 mg/dL (1.7 434    The Korean Journal of Internal Medicine Vol. 26, No. 4, December 2011
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mmol/L) or more, high-density lipoprotein (HDL) cho-
lesterol less than 40 mg/dL (1.0 mmol/L) in males or 50 
mg/dL (1.3 mmol/L) in females, blood pressure of 130/85 
mmHg or higher, or fasting glucose of 100 mg/dL (5.6 
mmol/L) or higher.
Laboratory analysis
All blood samples were drawn from an antecubital vein 
after at least 10 hours fasting. TSH and fT4 levels were an-
alyzed using a commercial chemiluminescent assay (Advia 
Centaur, Bayer, Tarrytown, NY, USA). Fasting blood glu-
cose, total cholesterol, triglyceride, and HDL cholesterol 
levels were assayed using an enzymatic method (Roche 
Diagnostics, Mannheim, Germany). Low-density lipopro-
tein (LDL) cholesterol was calculated using Friedewald’s 
formula.
Statistical analysis
Data are expressed as the mean ± SD unless otherwise 
stated. An independent-sample t test was used for each 
comparison between two independent groups. Analysis 
of variance (ANOVA) with post hoc analysis according to 
Tukey was used to compare data among age groups and 
seasons. Multiple linear regression was used for associa-
tion between lipid profile and TSH concentration with 
and without adjustment for age, sex, smoking status, obe-
sity, menopause status, and season. Multiple regression 
analysis was used to assess the independent association 
between TSH and serum lipid profile, adjusting for various 
risk factors. To examine the effect of TSH concentration on 
metabolic syndrome, the cohort was further categorized 
into five groups according to TSH concentration and ana-
lyzed by logistic regression. For all analyses, overall p val-
ues for trends are reported, and significance was assumed 
at p < 0.05. Analyses were conducted with SPSS version 
11.0 (SPSS Inc., Chicago, IL, USA).
Table 1. Baseline characteristics of the study population (n = 7,270)
Characteristics
Male
(n = 4,168)
Female
(n = 3,102)
Age, yr 44.2 ± 8.7 43.4 ± 9.8
Age group, yr   89 (2.1) 149 (4.8)
≤ 29
30-39   75 (30.6) 1,038 (33.5)
40-49 1,841 (44.2) 1,236 (39.8)
50-59 735 (17.6)   439 (14.2)
≥ 60 228 (5.5) 240 (7.7)
Hypertension, mmHg 410 (9.8)  153 (4.9)
Systolic blood press  121.9 ± 13.4 114.0 ± 13.6
Diastolic blood press   80.8 ± 10.9  63.7 ± 10.3
Waist circumference, cm 82.1 ± 9.1   78.9 ± 8.0
Height, cm 171.1 ± 5.9 158.7 ± 5.3
Weight, kg 71.3 ± 9.9 55.9 ± 7.4
Body mass index, kg/m
2 24.4 ± 3.2 22.3 ± 3.1
Serum glucose, mg/dL    94.8 ± 17.4  89.2 ± 12.0
Diabetes 112 (2.7)    44 (1.4)
Impaired fasting glucose 389 (9.3)  130 (4.2)
Total cholesterol, mg/dL 191.4 ± 32.9 181.4 ± 32.5
Triglyceride, mg/dL 149.6 ± 92.5  96.6 ± 54.9
High-density lipoprotein cholesterol, mg/dL 46.7 ± 9.9  55.0 ± 11.5
Low-density lipoprotein cholesterol, mg/dL 123.7 ± 29.2 112.1 ± 28.7
Values are presented as mean ± SD or number (%).Lee yK, et al. Normal serum TSH level and influencing factors     435
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RESULTS
Population characteristics and TSH concentra-
tions
The characteristics of the 7,270 subjects are shown in 
Table 1. We studied 4,168 males and 3,102 females aged 
20-89 years. Age distribution was similar in males and 
females. The mean TSH level of the study population was 
1.82 ± 0.95 mU/L (median, 1.62). The TSH concentration 
in males was significantly lower than that in females (1.67 
± 0.87 vs. 2.02 ± 1.01 mU/L, respectively, p < 0.001). The 
TSH distribution was skewed toward the high end; the 
distribution pattern in males and females was similar (data 
not shown). When the 2.5 and 97.5 percentiles were calcu-
lated, 95% TSH reference limits were 0.52-4.29 mU/L (Fig. 
1).
Factors associated with TSH concentration
Table 2 shows the association of TSH concentration 
with multiple factors. Subjects were divided into five sub-
groups according to age. As expected, those over 60 years 
had higher TSH concentrations than other age groups (p 
< 0.01), although TSH concentration difference among 
each age group younger than 60 years old was not statisti-
cally significant. Also, TSH during winter was significantly 
higher than during other seasons (spring, 1.79 ± 0.93 mU/L; 
summer, 1.74 ± 0.93 mU/L; fall, 1.78 ± 0.92 mU/L; winter, 
2.09 ± 1.06 mU/L; p < 0.01). Obese males had a higher 
TSH concentration than did non-obese males (2.00 ± 1.00 
vs. 1.63 ± 0.84 mU/L; p < 0.01). However, this was not 
observed in females, though there was a tendency toward 
a higher TSH in obese women (2.09 ± 1.05 vs. 1.73 ± 0.93 
mU/L, p = 0.064). Postmenopausal females showed a 
slightly higher TSH concentration than did premenopausal   
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Figure 1. Distribution of thyroid stimulating hormone (TSH) concentrations in the study population.436    The Korean Journal of Internal Medicine Vol. 26, No. 4, December 2011
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females (2.12 ± 1.09 vs. 2.00 ± 0.99, p < 0.01).
Serum lipid profile
Table 3 shows the association between serum TSH with-
in the reference range and lipid concentration. There was 
a significant positive correlation between TSH and total 
cholesterol (p = 0.003). After adjustment for age, sex, sea-
son, menopause status, and obesity, we found clear posi-
tive correlations of TSH with total cholesterol (p = 0.001), 
triglyceride (p = 0.001), and LDL cholesterol (p = 0.003), 
but not HDL cholesterol (p = 0.780). 
Table 2. TSH levels according to age, season, BMI, and menopause status
Variables No. TSH, mU/L p value
Age group, yr
≤ 29 - 1.87 ± 1.00
30-39  - 1.84 ± 0.93
40-49  - 1.77 ± 0.93
50-59  - 1.81 ± 0.97
≥ 60  - 1.93 ± 1.02 < 0.01
a
Season
Spring (Mar-May)   1,927 1.79 ± 0.93
Summer (jun-Aug)   2,396 1.74 ± 0.91
Fall (Sep-Nov)   1,820 1.78 ± 0.92
Winter (Dec-Feb)   1,127 2.09 ± 1.06 < 0.01
b
Obesity (BMI ≥ 25 kg/m
2)
Male Yes   1,657 2.00 ± 1.00 < 0.01
No   2,511 1.63 ± 0.84
Female Yes   517 2.09 ± 1.05 0.064
No   2,585   1.73 ± 0.93
Menopause
Pre-menopause   2,610 2.00 ± 0.99
Menopause   492  2.12 ± 1.09 0.01
TSH, thyroid stimulating hormone; BMI, body mass index.
aSignificant only between age group ≥ 60 and other ages.
bSignificant only between winter and other seasons.
Table 3. Correlation coefficients between serum thyroid stimulating hormone and lipid levels
Serum lipid β p value
Model 1
a Total cholesterol 0.035 0.003
Triglyceride -0.005 0.367
High-density lipoprotein cholesterol 0.056 0.001
Low-density lipoprotein cholesterol 0.016 0.170
Model 2
b Total cholesterol 0.048 0.001
Triglyceride 0.039 0.001
High-density lipoprotein cholesterol 0.003 0.780
Low-density lipoprotein cholesterol 0.035 0.003
aUnadjusted data.
bAdjusted for sex, age, season, menopause status, and obesity.Lee yK, et al. Normal serum TSH level and influencing factors     437
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Metabolic syndrome
The overall percentage of metabolic syndrome in eu-
thyroid subjects according to the ATP III definition was 
12.9 and 11.0% in males and females, respectively. Table 
4 shows the prevalence of metabolic syndrome in five 
groups stratified by TSH concentration. The percentage of 
subjects with metabolic syndrome consistently and signifi-
cantly increased with TSH concentration (p < 0.05).
DISCUSSION
The definition of the normal range of serum TSH re-
mains controversial. This issue is important because the 
normal range provides a framework to categorize patients 
as normal or as having subclinical or overt thyroid dis-
ease.
We report the findings of our population-based study 
on the reference range of TSH concentration and the as-
sociation of TSH with lipid concentration and metabolic 
syndrome. TSH was negatively correlated with lipid con-
centration after adjustment for factors that can affect its 
concentration. Furthermore, we found that participants 
with high-normal TSH levels had an almost two-fold high-
er risk of metabolic syndrome compared to those within 
reference group. These findings are consistent with the 
well-established relationship between overt hypothyroid-
ism and lipid concentration [15]. Several epidemiologic 
studies have shown that increased lipid concentration is 
associated with (subclinical) hypothyroidism; this ex-
plains the increased prevalence of cardiovascular disease 
in patients with (subclinical) hypothyroidism [7,9,16,17]. 
These phenomena are obvious in hypothyroidism but 
remain controversial in subclinical hypothyroidism. This 
argument raises the question of the normal range of TSH 
concentration [5,6,18].
The lower limit of TSH is less debated; most discussions 
are of how to define the upper limit of TSH, suggesting that 
the upper normal limit should be decreased to 2.5 mU/L [19]. 
A growing body of literature describes the adverse effects 
of subclinical thyroid disease and the benefits of T4 treat-
ment [20-23]. Moreover, new National Academy of Clinical 
Biochemistry (NACB) guidelines state that more than 95% 
of healthy, euthyroid subjects had a serum TSH concentra-
tion of 0.4-2.5 mU/L [19]. The mean TSH concentration 
in our study was 1.81 ± 0.95 mU/L; this is lower than the 
median value, and the distribution curve was skewed to 
the right. Total cholesterol, triglyceride, and LDL choles-
terol levels increased with TSH level within the reference 
range, as did the prevalence of metabolic syndrome. It is 
noteworthy that the positive association between serum 
lipid levels and TSH concentration was still significant 
after adjustment for several confounding variables such as 
age, sex, and obesity. Our study emphasized that people 
who are categorized as being euthyroid are susceptible to 
metabolic syndrome, itself a cluster of cardiovascular risk 
factors. Increased TSH concentration, even within the 
currently accepted reference range, may have long-term 
detrimental effects on cardiovascular health. Therefore, 
subjects with high normal TSH should be carefully as-
sessed for early thyroid dysfunction, which is a risk factor 
for atherosclerosis. 
TSH can be influenced by several factors. TSH shows di-
urnal variation, being high at night and low in the morning 
[24]. Fasting status [25] and estrogen [26] also affect TSH 
levels. However, conflicting factors such as fasting status 
or diurnal change were excluded in our study because all 
blood samples were taken at 8-10 AM, after fasting. Thy-
roid dysfunction in the elderly is more prevalent than in 
the young [27]. Moreover, the prevalence of thyroglobulin 
Table 4. ORs for metabolic syndrome by TSH concentration 
TSH, mU/L No. No. of metabolic syndrome OR 95% CI
0.35-1.38 2,502 308 1.0 (Ref)
1.39-2.41 2,520 345 1.112 0.945-1.309
2.42-3.44 949 146 1.250 1.012-1.543
3.45-4.47 306 53 1.407 1.027-1.927
4.48-5.5 114 27 1.924 1.244-2.975
TSH, thyroid stimulating hormone; OR, odds ratio; CI, confidence interval; Ref, reference group.438    The Korean Journal of Internal Medicine Vol. 26, No. 4, December 2011
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antibodies and thyroid peroxidase antibodies increases 
with age, according to the NHANES III report [27]. There-
fore, our report of increased TSH concentration in subjects 
above 60 years is consistent with these data. 
Data in the United States National Health and Nutri-
tion Examination Survey (NHANES) suggested that TSH 
levels differ between Blacks and Whites in the US [28]. 
Several epidemiologic studies have reported the normal 
range of TSH concentration in the Korean population [29-
32]. These studies show a slightly different TSH reference 
range from that in American or European populations. 
Lee et al. [29] reported 0.39-3.68 mIU/L in 317 patients, 
Jung et al. [30] 0.34-3.28 mIU/L, and Jang et al. [31] 0.47-
8.76 mIU/L as a TSH normal reference range. Our study 
included a relatively large population and different age 
groups. However, further studies are required to docu-
ment the normal reference range in the Korean popula-
tion, and the relationship with clinical presentation should 
be considered.
The limitation of our study is that it was a cross-section-
al, so a cause and effect relationship cannot be discerned. 
However, this study included a rather large number of sub-
jects who visited our clinics for a routine health check-up 
and are considered to be healthy members of the general 
population. Also, we could not obtain data regarding thy-
roid autoimmunity, which represents unreported underly-
ing thyroid disease and may influence TSH concentration. 
Subjects with thyroid auto-antibody positivity tend to have 
higher TSH concentrations regardless of ethnicity [27]. 
If we exclude participants who may have been antibody-
positive, the TSH reference range would be narrower than 
that found in this study. Finally, we checked TSH only 
once, even though whether a single TSH measurement re-
flects the individual’s average TSH measurement over time 
remains unknown.
In summary, we report a population-based TSH refer-
ence range of 0.52-4.29 mU/L in a general Korean popula-
tion sample. TSH concentration was influenced by age, sex, 
season, menopausal status and obesity (in males only). 
Further, TSH concentration within the normal range was 
negatively correlated with serum lipid level, and high-
normal TSH levels were significantly associated with an 
increased prevalence of metabolic syndrome. An addition-
al study is needed to define TSH concentration and should 
include measurement of thyroid auto-antibody. This will 
provide evidence of the optimal method of treating early-
stage mild thyroid dysfunction. The clinical significance 
of high-normal TSH levels with regard to cardiovascular 
prognosis should be determined in prospective studies. 
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